Published November 2019
| Version v1
Journal article
How research reactors help make medical imaging possible
Creators
Description
More than 80% of the medical imaging used each year to diagnose diseases like cancer is made possible by the pharmaceutical drugs produced, for the most part, in research reactors. These radiopharmaceuticals contain the radioisotope technetium-99m (99mTc ), which comes from the radioisotope molybdenum-99 (99Mo) that is primarily produced in research reactors.
Availability note (English)
Also available on-line: https://www.iaea.org/sites/default/files/publications/magazines/bulletin/bull60-4/6041213.pdfAdditional details
Identifiers
Publishing Information
- Journal Title
- IAEA Bulletin (Online)
- Journal Volume
- 60
- Journal Issue
- 4
- Journal Page Range
- p. 12-13
- ISSN
- 1564-2690
INIS
- Country of Publication
- International Atomic Energy Agency (IAEA)
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 51006411
- Subject category
- S07: ISOTOPES AND RADIATION SOURCES; S21: SPECIFIC NUCLEAR REACTORS AND ASSOCIATED PLANTS;
- Descriptors DEI
- BIOMEDICAL RADIOGRAPHY; ISOTOPE PRODUCTION; MOLYBDENUM 99; NEOPLASMS; RADIOPHARMACEUTICALS; RESEARCH REACTORS; TECHNETIUM 99
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; DAYS LIVING RADIOISOTOPES; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; EVEN-ODD NUCLEI; HOURS LIVING RADIOISOTOPES; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; MATERIALS; MEDICINE; MOLYBDENUM ISOTOPES; NUCLEAR MEDICINE; NUCLEI; ODD-EVEN NUCLEI; RADIOACTIVE MATERIALS; RADIOISOTOPES; RADIOLOGY; REACTORS; RESEARCH AND TEST REACTORS; TECHNETIUM ISOTOPES; YEARS LIVING RADIOISOTOPES